Mike Biotech: Shareholders with more than 5% of the shares end the reduction plan ahead of schedule and terminate the concerted action relationship.

Mike Bio announced that Guo Lei, a shareholder holding more than 5% of the shares, and his concerted action person originally planned to reduce their holdings by up to 16,327,928 shares from July 17, 2025 to October 14, 2025, accounting for 2.68% of the total share capital. As of September 28, a total of 16,027,928 shares have been sold, and the reduction plan has been terminated early. Among them, Guo Lei sold 5.45 million shares in block transactions at an average price of 10.01 yuan/share; Axin Yan'an 20th Fund sold a total of 6,273,328 million shares through centralized bidding and block transactions; Axin Yan'an 22nd Fund sold 4.3046 million shares in block transactions. After the reduction, the combined shareholding percentage of the three parties decreased from 7.6658% to 5.0151%. As both funds of Axin have completed their reduction, the concerted action relationship with Guo Lei has been automatically terminated. This reduction is in compliance with regulations and does not affect the company's control rights.